PhaseBio Pharmaceuticals (Global Rights to PB6440) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

PhaseBio Pharmaceuticals (Global Rights to PB6440) General Information

Description

Global rights to PB6440 in the cardiovascular field.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • One Great Valley Parkway
  • Suite 30
  • Malvern, PA 19355
  • United States
Primary Industry
Buildings and Property
Acquirer
CORXEL Pharmaceuticals
Corporate Office
  • One Great Valley Parkway
  • Suite 30
  • Malvern, PA 19355
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PhaseBio Pharmaceuticals (Global Rights to PB6440) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PhaseBio Pharmaceuticals (Global Rights to PB6440)‘s full profile, request access.

Request a free trial

PhaseBio Pharmaceuticals (Global Rights to PB6440) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PhaseBio Pharmaceuticals (Global Rights to PB6440)‘s full profile, request access.

Request a free trial

PhaseBio Pharmaceuticals (Global Rights to PB6440) FAQs

  • Where is PhaseBio Pharmaceuticals (Global Rights to PB6440) headquartered?

    PhaseBio Pharmaceuticals (Global Rights to PB6440) is headquartered in Malvern, PA.

  • What industry is PhaseBio Pharmaceuticals (Global Rights to PB6440) in?

    PhaseBio Pharmaceuticals (Global Rights to PB6440)’s primary industry is Buildings and Property.

  • Is PhaseBio Pharmaceuticals (Global Rights to PB6440) a private or public company?

    PhaseBio Pharmaceuticals (Global Rights to PB6440) is a Private company.

  • What is PhaseBio Pharmaceuticals (Global Rights to PB6440)’s current revenue?

    The current revenue for PhaseBio Pharmaceuticals (Global Rights to PB6440) is .

  • Who are PhaseBio Pharmaceuticals (Global Rights to PB6440)’s investors?

    PhaseBio Pharmaceuticals has invested in PhaseBio Pharmaceuticals (Global Rights to PB6440).

  • When was PhaseBio Pharmaceuticals (Global Rights to PB6440) acquired?

    PhaseBio Pharmaceuticals (Global Rights to PB6440) was acquired on 03-Feb-2023.

  • Who acquired PhaseBio Pharmaceuticals (Global Rights to PB6440)?

    PhaseBio Pharmaceuticals (Global Rights to PB6440) was acquired by CORXEL Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process